Talc in Treating Patients With Malignant Pleural Effusion
A phase 3 trial of Talc in Metastatic cancer, run by Alliance for Clinical Trials in Oncology, completed.
Overview
Talc in Treating Patients With Malignant Pleural Effusion is a phase 3 interventional study registered as NCT00002622 by Alliance for Clinical Trials in Oncology, with 501 participants recorded, started 1994-12 and reaching its primary completion in 2005-03. Interventions recorded: talc, Talc. Conditions recorded: Metastatic Cancer.
Linked to the drug Talc because the registry names it among its interventions and Metastatic cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialVideo-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
Shares Talc (intrapleural), Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialBleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
Shares Talc (intrapleural), Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialInvestigation of a Therapeutic Vaccine (ACIT-1) in Cancer
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPlasmodium Immunotherapy for Advanced Malignant Solid Tumors
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPhase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialAuger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialSafety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialOsteosarcoma Maintenance Therapy With OST31-164
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.